Skip to content

Investment frenzy of 2021 ends as number of new unicorns nosedives in 2022

Investment frenzy of 2021 ends as number of new unicorns nosedives in 2022
Dino Kurbegovic

It is almost impossible to stop innovation, it can be slowed down due to various factors, such as a gloomy economy, the likes of which 2022 has given birth, but ultimately innovation will march on. 

The investment frenzy witnessed in 2021 has come to an end, with new datasets coming out to confirm this fact in various market segments. While in 2021, the startup scene saw $621 billion year-on-year (YoY) investments and the birth of 537 unicorns (companies worth over $1 billion), 2022 will pale in comparison. 

Namely, fewer unicorns are being minted per quarter, with Q2 2022 seeing ‘only’ 87 new unicorn births, according to CBInsights data, released on September 14. Q3 data looks even worse, with the birth of only 27 unicorns for the quarter.

Number of new unicorns. Source: CBInsights 

What is driving the trend? 

An unstable macro environment is one of the major reasons less funding is available for private companies, putting pressure on investors and driving down returns of risk assets in general. In addition, fintech companies have had a rough 2022 with the second largest quarterly drop in a decade, with valuations of even the major players in the sectors being halved, at best. 

Investors that are sitting on cash or that have accumulated cash prior to the 2022 slump now face the trouble of numerous investment options, and with prospects of lower returns, they seem more reluctant to invest. 

Regional bias  

For the first time, Europe has passed Asia in the quarterly share of new unicorns, with SonarSource, BackBase, and Oura leading the way, being valued at $4.7 billion, $2.7 billion, and $2.6 billion, respectively. Nonetheless, the environment in which central banks raise interest rates across the globe will probably even out the decline across all regions.

Geographical quarterly share of new unicorns. Source: CBInsights 

With the drop becoming more pronounced following a prosperous year for unicorns in 2021, this might ultimately be a beneficial development, as unicorns and prospective unicorns will be forced to concentrate on more sustainable business methods, potentially attempting to survive on their own, therefore establishing more resilient cultures for the benefit of everybody.

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.    

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.